Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results

Published:2007-03 Issue:4 Volume:17 Page:235-244
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Haro Josep Maria,Suarez David,Novick Diego,Brown Jacqueline,Usall Judith,Naber Dieter

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference30 articles.

1. Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care;Ascher-Svanum;J. Clin. Psychiatry,2006

2. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia;Ascher-Svanum;BMC Psychiatry,2006

3. A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or schizoaffective disorder;Conley;Am. J. Psychiatry,2001

4. Ambulatory use of olanzapine and risperidone: a population-based study on persistence and the use of concomitant therapy in the treatment of schizophrenia;Cooper;Can. J. Psychiatry,2005

5. Antipsychotic prescribing practices in Connecticut's Public Mental Health System: rates of changing medications and prescribing styles;Covell;Schizophr. Bull.,2002

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Low-dose Olanzapine in Combination with Sertraline on Negative Symptoms and Psychosocial Functioning in Schizophrenia: A Randomized Controlled Trial;Current Neuropharmacology;2024-07

2. Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review;Brain Sciences;2024-04-26

3. Reduction in Multiple Cardiometabolic Risk Factors With Combined Olanzapine/Samidorphan Compared With Olanzapine: Post Hoc Analyses From a 24-Week Phase 3 Study;Schizophrenia Bulletin;2022-10-28

4. Olanzapine/Samidorphan: A New Combination Treatment for Schizophrenia and Bipolar I Disorder Intended to Reduce Weight Gain;CNS Drugs;2022-05-30

5. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?;Expert Review of Neurotherapeutics;2022-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3